PMH41 COST-UTILITY ANALYSIS OF ESCITALOPRAM VERSUS CITALOPRAM IN MAJOR DEPRESSIVE DISORDER IN ISRAEL
Abstract
Authors
M Leshno Y Ben-Amnon M Brignone F Marteau K Hansen
M Leshno Y Ben-Amnon M Brignone F Marteau K Hansen
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now